Rho (D) immune globulin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rh o (D)-negative women to reduce likelihood of hemolytic disease in Rh o (D)-positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rh o (D)-positive pts.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rh o (D)-negative women to reduce likelihood of hemolytic disease in Rh o (D)-positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rh o (D)-positive pts.
There's more to see -- the rest of this entry is available only to subscribers.